These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16789060)

  • 1. Animal intelligence.
    Hoag H
    Nature; 2006 May; 441(7092):544-5. PubMed ID: 16789060
    [No Abstract]   [Full Text] [Related]  

  • 2. Legacy data sharing to improve drug safety assessment: the eTOX project.
    Sanz F; Pognan F; Steger-Hartmann T; Díaz C; ; Cases M; Pastor M; Marc P; Wichard J; Briggs K; Watson DK; Kleinöder T; Yang C; Amberg A; Beaumont M; Brookes AJ; Brunak S; Cronin MTD; Ecker GF; Escher S; Greene N; Guzmán A; Hersey A; Jacques P; Lammens L; Mestres J; Muster W; Northeved H; Pinches M; Saiz J; Sajot N; Valencia A; van der Lei J; Vermeulen NPE; Vock E; Wolber G; Zamora I
    Nat Rev Drug Discov; 2017 Dec; 16(12):811-812. PubMed ID: 29026211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent efforts to elucidate the scientific validity of animal-based drug tests by the pharmaceutical industry, pro-testing lobby groups, and animal welfare organisations.
    Bailey J; Balls M
    BMC Med Ethics; 2019 Mar; 20(1):16. PubMed ID: 30823899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The right combination.
    Nature; 2006 Jan; 439(7075):390-1. PubMed ID: 16437083
    [No Abstract]   [Full Text] [Related]  

  • 5. Workshop on evaluation of pediatric long-term neurocognitive development and medical products.
    McMahon AW; Kapcala LP; Sheridan PH
    Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1428-1430. PubMed ID: 28924994
    [No Abstract]   [Full Text] [Related]  

  • 6. Consider drug efficacy before first-in-human trials.
    Kimmelman J; Federico C
    Nature; 2017 Jan; 542(7639):25-27. PubMed ID: 28150789
    [No Abstract]   [Full Text] [Related]  

  • 7. Translational medicine 2006.
    Persiani S
    IDrugs; 2006 Apr; 9(4):253-5. PubMed ID: 16596476
    [No Abstract]   [Full Text] [Related]  

  • 8. Stroke drug development: usually, but not always, animal models.
    Donnan GA; Davis SM
    Stroke; 2005 Oct; 36(10):2326. PubMed ID: 16141427
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of animal models has not contributed to development of acute stroke therapies: pro.
    Kaste M
    Stroke; 2005 Oct; 36(10):2323-4. PubMed ID: 16141431
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of animal models has not contributed to development of acute stroke therapies: con.
    Fisher M; Tatlisumak T
    Stroke; 2005 Oct; 36(10):2324-5. PubMed ID: 16141429
    [No Abstract]   [Full Text] [Related]  

  • 11. Extrapolation of preclinical data into clinical reality translational science.
    Singer T
    Ernst Schering Res Found Workshop; 2007; (59):1-5. PubMed ID: 17117711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspective of humanized mouse models for assessing PK/PD and toxic profile of drug candidates in preclinical study.
    Chiba K
    Drug Metab Pharmacokinet; 2014; 29(1):1-2. PubMed ID: 24573168
    [No Abstract]   [Full Text] [Related]  

  • 13. MRI in preclinical drug development.
    Silva MD; Chandra S
    Methods Mol Med; 2006; 124():299-322. PubMed ID: 16506427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploratory toxicology as an integrated part of drug discovery. Part II: Screening strategies.
    Hornberg JJ; Laursen M; Brenden N; Persson M; Thougaard AV; Toft DB; Mow T
    Drug Discov Today; 2014 Aug; 19(8):1137-44. PubMed ID: 24374152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Industrial research in the quest for new medicines.
    Berde B
    Clin Exp Pharmacol Physiol; 1974; 1(3):183-95. PubMed ID: 4617642
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding drug targets: no such thing as bad news.
    Roberts RA
    Drug Discov Today; 2018 Dec; 23(12):1925-1928. PubMed ID: 29803936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Industry concern over EU hepatotoxicity guidance.
    Hughes B
    Nat Rev Drug Discov; 2008 Sep; 7(9):719. PubMed ID: 19172685
    [No Abstract]   [Full Text] [Related]  

  • 18. Points to Consider in Designing and Conducting Juvenile Toxicology Studies.
    Kim NN; Parker RM; Weinbauer GF; Remick AK; Steinbach T
    Int J Toxicol; 2017; 36(4):325-339. PubMed ID: 28466670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zebrafish based assays for the assessment of cardiac, visual and gut function--potential safety screens for early drug discovery.
    Berghmans S; Butler P; Goldsmith P; Waldron G; Gardner I; Golder Z; Richards FM; Kimber G; Roach A; Alderton W; Fleming A
    J Pharmacol Toxicol Methods; 2008; 58(1):59-68. PubMed ID: 18585469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of preclinical animal models in breast cancer drug development.
    Clarke R
    Breast Cancer Res; 2009; 11 Suppl 3(Suppl 3):S22. PubMed ID: 20030874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.